Eve Investments Ltd (EVE)

Currency in AUD
0.017
-0.001(-5.56%)
Closed·
EVE is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.0170.018
52 wk Range
0.0140.036
Key Statistics
Bid/Ask
0.017 / 0.018
Prev. Close
0.018
Open
0.018
Day's Range
0.017-0.018
52 wk Range
0.014-0.036
Volume
165.93K
Average Volume (3m)
455.51K
1-Year Change
-39.2857%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
EVE Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Earnings

Latest Release
Aug 31, 2026
EPS / Forecast
-- / --
Revenue / Forecast
520.23K / --
EPS Revisions
Last 90 days

EVE Income Statement

Compare EVE to Peers and Sector

Metrics to compare
EVE
Peers
Sector
Relationship
P/E Ratio
−3.2x−2.4x11.3x
PEG Ratio
−0.07−0.020.03
Price/Book
1.5x0.9x1.5x
Price / LTM Sales
5.2x1.6x0.9x
Upside (Analyst Target)
-51.9%25.6%
Fair Value Upside
Unlock14.8%13.6%Unlock

EVE Health Group Limited, a life sciences and healthcare company, engages in the development and commercialization of pharmaceutical products in Australia. It operates in two segments, Meluka (Branded Wellness Consumer Products) and Nextract (Pharmaceutical Products and Intellectual Property). Its lead product is the Dyspro, a formulation developed to address dysmenorrhoea and Endometriosis Pain; and Libbo, an oral dissolving film for erectile dysfunction. The company also develops Apixaban to treat anticoagulation. The company was formerly known as EVE Investments Limited. EVE Health Group Limited was incorporated in 2003 and is based in Subiaco, Australia.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
95.07M26.98%1.71M
Public Companies & Retail Investors
257.26M73.02%4.63M
Total
352.33M100.00%6.34M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
A-Won Pharma Pty Ltd14.65%51,608,528929
Everhoney Biotech Australia Pty. Ltd.4.69%16,513,069297

FAQ

What Is the Eve Investments (EVE) Stock Price Today?

The Eve Investments stock price today is 0.017 AUD.

What Stock Exchange Does Eve Investments Trade On?

Eve Investments is listed and trades on the Sydney Stock Exchange.

What Is the Stock Symbol for Eve Investments?

The stock symbol for Eve Investments is "EVE."

What Is the Eve Investments Market Cap?

As of today, Eve Investments market cap is 5.990M AUD.

What Is Eve Investments's Earnings Per Share (TTM)?

The Eve Investments EPS (TTM) is -0.007.

From a Technical Analysis Perspective, Is EVE a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Eve Investments Stock Split?

Eve Investments has split 4 times.

What is the current trading status of Eve Investments (EVE)?

As of Sep 12, 2026, Eve Investments (EVE) is trading at a price of 0.017 AUD, with a previous close of 0.018 AUD. The stock has fluctuated within a day range of 0.017 AUD to 0.018 AUD, while its 52-week range spans from 0.014 AUD to 0.036 AUD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.